Stock Events

Stock Events

Medartis 

$115
8
+$15.04+15.05% Monday 13:30

Statistics

Day High
115
Day Low
115
52W High
115
52W Low
66.68
Volume
-
Avg. Volume
-
Mkt Cap
1.57B
P/E Ratio
135.29
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17MarExpected
Q4 2022
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.03
0.3
0.64
0.97
Expected EPS
N/A
Actual EPS
N/A

Financials

1.57%Profit Margin
Profitable
2021
2022
2023
2024
496.67MRevenue
7.8MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDRSF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap112.88B
Stryker Corporation is a direct competitor in the orthopedic implant market, offering similar products for bone fixation.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, providing solutions that overlap with Medartis' offerings.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its DePuy Synthes division, offers orthopedic and neurosurgery products that compete with Medartis' portfolio.
Medtronic
MDT
Mkt Cap102.71B
Medtronic plc provides medical devices that include orthopedic solutions, directly competing in the same space as Medartis.
Globus Medical
GMED
Mkt Cap12.39B
Globus Medical, Inc. focuses on spine and orthopedic implants, competing in similar markets as Medartis.
Alphatec
ATEC
Mkt Cap1.59B
Alphatec Holdings, Inc. specializes in spine surgery products, overlapping with Medartis' focus on orthopedic surgical products.
Orthofix Medical
OFIX
Mkt Cap478.12M
Orthofix Medical Inc. offers orthopedic products and regenerative solutions that compete with Medartis in the orthopedic sector.
K2 Capital Acquisition
KTWO
Mkt Cap1.2B
K2M Group Holdings, Inc. provides spine and minimally invasive solutions, competing in the broader orthopedic market alongside Medartis.

About

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
Show more...
CEO
Mr. Matthias Schupp
Employees
816
Country
Switzerland
ISIN
CH0386200239

Listings

F
DE
1RU.F
OTC Link
US
MDRSF
MU
DE
1RU.MU
SW
CH
MED.SW

0 Comments

Share your thoughts

FAQ

What is Medartis stock price today?▼
The current price of MDRSF is $115 USD — it has increased by +15.05% in the past 24 hours. Watch Medartis stock price performance more closely on the chart.
What is Medartis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medartis stocks are traded under the ticker MDRSF.
What is Medartis market cap?▼
Today Medartis has the market capitalization of 1.57B
When is the next Medartis earnings date?▼
Medartis is going to release the next earnings report on August 18, 2026.
What is Medartis revenue for the last year?▼
Medartis revenue for the last year amounts to 496.67M USD.
What is Medartis net income for the last year?▼
MDRSF net income for the last year is 7.8M USD.
How many employees does Medartis have?▼
As of May 06, 2026, the company has 816 employees.
In which sector is Medartis located?▼
Medartis operates in the Health & Wellness sector.
When did Medartis complete a stock split?▼
The last stock split for Medartis was on June 01, 2018 with a ratio of 1:10.
Where is Medartis headquartered?▼
Medartis is headquartered in Basel, Switzerland.